Sign in
4

Changes in Ownership

CYTOKINETICS INC Filed Acc 0001127602-24-024077

President & CEO sold 5,000 shares at $55.99 ($279,950)

  • President & CEO acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Blum Robert I President & CEO 2024-09-16 Option exercise 10b5-1 +5,000 $6.67 $33,350 402,456 D
Blum Robert I President & CEO 2024-09-16 Sale 10b5-1 −5,000 $55.99 $279,950 397,456 D
Derivatives
Blum Robert I President & CEO 2024-09-16 Option exercise · Non-Qualified Stock Option (Right to Buy) 10b5-1 −5,000 79,727 D
Open-market sales · 5,000 sh · avg $55.99 · $279,950
Loading xslF345X05/form4.xml…